companydata.dkcompanydata.dk

REVERS F.M.B.A: Financial statements 2024

CVR: 44127474

Source: annual report 2024, Danish Business Authority

01/01/2024 – 31/12/2024

REVERS F.M.B.A (CVR 44127474) has filed annual accounts for 2024. In 2024, the company reported a gross profit of DKK -82,861 and a net result of DKK 0. Equity in the 2024 report amounted to DKK 0.

Revenue
DKK 0
Gross Profit
DKK -82,861
Equity
DKK 0

Official annual report

View the official annual report directly on the page with a Pro subscription.

Screen every Danish company

Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.

Try company screening

Events in 2024

REVERS F.M.B.A publishes interim reportJul 5, 2024

REVERS F.M.B.A has published its interim report for the period May 23, 2023 to December 31, 2023.

Placebo F.M.B.A changes name to REVERS F.M.B.AApr 27, 2024

On April 27, 2024, the company changed its name from Placebo F.M.B.A to REVERS F.M.B.A.

About REVERS F.M.B.A

REVERS F.M.B.A is a Danish company of the type Forening med begrænset ansvar based in København V, founded in 2023. The company is registered under the industry Teater- og koncertproduktioner. The company was previously named Placebo F.M.B.A. The management consists of Johanne Petrine Reynberg and Martin Ivan Lars Sørensen. The board consists of Pelle Andreas Reynberg (chair), Amanda Theresia Holman Brogaard-Walsh and Frida Marie Reynberg. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported revenue of DKK 15,000 and a net result of DKK 1,880 compared with DKK 0 the year before. Equity in the 2025 report amounted to DKK 1,882.

Source: annual report 2025, Danish Business Authority

Other financial years